Ninety One UK Ltd Makes New Investment in DENTSPLY SIRONA Inc. $XRAY

Ninety One UK Ltd bought a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm bought 1,159,840 shares of the medical instruments supplier’s stock, valued at approximately $18,418,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in XRAY. Envestnet Asset Management Inc. increased its stake in DENTSPLY SIRONA by 9.0% in the first quarter. Envestnet Asset Management Inc. now owns 494,737 shares of the medical instruments supplier’s stock valued at $7,391,000 after acquiring an additional 40,936 shares during the last quarter. Brown Advisory Inc. acquired a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at $679,000. Dynamic Technology Lab Private Ltd bought a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at $366,000. Krilogy Financial LLC acquired a new position in shares of DENTSPLY SIRONA during the 2nd quarter worth $336,000. Finally, Counterpoint Mutual Funds LLC bought a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth $402,000. Institutional investors own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on XRAY. Barrington Research decreased their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating on the stock in a research report on Friday, August 8th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research note on Friday, September 26th. Wall Street Zen raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, September 26th. UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a research report on Friday, August 8th. Finally, Wells Fargo & Company cut their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating on the stock in a research report on Friday, August 8th. Two research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $18.64.

DENTSPLY SIRONA Stock Up 2.0%

NASDAQ:XRAY opened at $12.95 on Thursday. DENTSPLY SIRONA Inc. has a one year low of $12.14 and a one year high of $25.76. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The company has a market cap of $2.58 billion, a PE ratio of -2.73, a P/E/G ratio of 0.79 and a beta of 0.96. The firm’s 50 day simple moving average is $13.92 and its 200 day simple moving average is $14.76.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.02. The firm had revenue of $936.00 million during the quarter, compared to analysts’ expectations of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The company’s revenue was down 4.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $0.64 annualized dividend and a yield of 4.9%. DENTSPLY SIRONA’s payout ratio is presently -13.50%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.